Cargando…
Oral Liushen pill for patients with COVID‐19: A prospective randomized controlled trial
We examined the efficacy and safety of Liushen pill combined with basic treatment for patients with COVID‐19. In total, 181 patients hospitalized with COVID‐19, classified as asymptomatic mild type, were randomly divided into the experimental (n = 91) and control (n = 90) groups and were administere...
Autores principales: | Zhang, Jianping, Liu, Yian, Lei, Wei, Shen, Junheng, Lu, Jing, Tao, Tao, Cao, Xu, Yang, Zhong, Huang, Jianan, Shi, Cuilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886519/ https://www.ncbi.nlm.nih.gov/pubmed/36733313 http://dx.doi.org/10.1002/pul2.12187 |
Ejemplares similares
-
Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial
por: Ma, Qinhai, et al.
Publicado: (2022) -
Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial
por: Ma, Qinhai, et al.
Publicado: (2023) -
Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro
por: Ma, Qinhai, et al.
Publicado: (2022) -
Efficacy and safety of Zuojin Pill for chronic gastritis: Protocol for a systematic review of randomized controlled trials
por: Shi, Jianglong, et al.
Publicado: (2020) -
The quality of reporting of randomized controlled trials of HuatuoZaizao pill for stroke
por: Zhang, Xiao-Jie, et al.
Publicado: (2023)